UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Functional Recovery After Acute Myocardial Infarction

Journal of the American College of Cardiology, 2008-07, Vol.52 (3), p.181-189

2008

Volltextzugriff (PDF)

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

JACC. Cardiovascular interventions, 2020-05, Vol.13 (9), p.1100-1109

2020

Volltextzugriff (PDF)

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018-10, Vol.14 (9), p.e1049

2018

Volltextzugriff (PDF)

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Journal of the American Heart Association, 2022-11, Vol.11 (22), p.e026041-e026041

2022

Volltextzugriff (PDF)

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012-07, Vol.8 (3), p.336

2012

Volltextzugriff (PDF)

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

The American journal of cardiology, 2012-12, Vol.110 (11), p.1561-1567

2012

Volltextzugriff (PDF)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association, 2018-02, Vol.7 (3), p.n/a

2018

Volltextzugriff (PDF)

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial

Journal of the American College of Cardiology, 2012-04, Vol.59 (15), p.1350-1361

2012

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease

Atherosclerosis, 2024-05, Vol.392, p.117488-117488, Article 117488

2024

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury

Journal of the American College of Cardiology, 2008-07, Vol.52 (3), p.181-189

2008

Volltextzugriff (PDF)

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Atherosclerosis, 2022-08, Vol.355, p.52-59

2022

Volltextzugriff (PDF)

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Catheterization and cardiovascular interventions, 2009-05, Vol.73 (6), p.781-786

2009

Volltextzugriff (PDF)

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

The American heart journal, 2016-06, Vol.176, p.28-35

2016

Volltextzugriff (PDF)

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

International journal of cardiology, 2023-03, Vol.374, p.27-32

2023

Volltextzugriff (PDF)

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2406-2416

2013

Volltextzugriff (PDF)

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017-11, Vol.13 (10), p.1168

2017

Volltextzugriff (PDF)

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II)

The American heart journal, 2016-05, Vol.175, p.121-129

2016

Volltextzugriff (PDF)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.462-469

2018

Volltextzugriff (PDF)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Catheterization and cardiovascular interventions, 2020-11, Vol.96 (5), p.E508-E515

2020

Volltextzugriff (PDF)

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

International journal of cardiology, 2021-02, Vol.325, p.37-44

2021

Volltextzugriff (PDF)

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.448-459

2018

Volltextzugriff (PDF)

Staged Therapeutic Approach in Spontaneous Coronary Dissection

The Annals of thoracic surgery, 2007-05, Vol.83 (5), p.1879-1881

2007

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

KollektionEBSCO_Psychology & Behavioral Sciences Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(99)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(102)
Japanisch
(13)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(69)
Cardiac & Cardiovascular Systems
(59)
Cardiovascular System & Cardiology
(59)
Humans
(57)
Male
(47)
Female
(46)
Middle Aged
(45)
Percutaneous Coronary Intervention
(43)
Aged
(39)
Treatment Outcome
(30)
Drug-Eluting Stents
(28)
Drug-Eluting Stent
(22)
Heart Attacks
(21)
Cardiology
(20)
Risk Factors
(20)
Stents
(20)
Cardiovascular
(18)
Percutaneous Coronary Intervention - Adverse Effects
(18)
Coronary Artery Disease
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Functional Recovery After Acute Myocardial Infarction

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Aspiration of embolized thrombus during primary percutaneous coronary intervention

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study

Staged Therapeutic Approach in Spontaneous Coronary Dissection

Aktive Filter

Suchergebnisse filtern